Archive for November, 2010

Inside Health Care: Exploring Accountable Care Organizations

CFAH Staff
Tuesday, November 30th, 2010

On Concurring Opinions, Frank Pasquale J.D., law professor at Seton Hall, describes an ACO as a way to reduce fragmentation of care in his post “Health Reform and Accountable Care Organizations”. ACOs create an “extended hospital” where a “virtual network” of physicians team up with hospitals and agree to be compensated by lump sum payments. If the group keeps costs below payments, gains are shared among members. An incentive exists to work together to keep people healthy. But he cautions, “ACOs could quickly have negative unintended consequences if regulators fail to anticipate the ways they could be abused.”

In The New England Journal of Medicine November Perspectives piece, “Patients’ Role in Accountable Care Organizations,” Anna D. Sinaiko Ph.D. and Meredith B. Rosenthal Ph.D. say, “Understandably, much of the debate about ACOs has focused on structuring provider networks, reimbursing providers, and designing performance-based rewards and penalties for providers. Largely missing from these discussions is a role for patients.” They discuss that for many, “ACO-like models, including Medicare’s Physician Group Practice Demonstration project, patients have been assigned to an ACO through “invisible enrollment,” with no prospective notification and sometimes no awareness that they have been associated with an ACO. Sinaiko and Rosenthal remind us of the past “pitfalls of capitations arrangements” where patients were excluded, warning for ACOs to include consumers.

Vince Kuratis J.D., M.B.A., asks, “Does This ACO Thing Really Mean We Need to Be ‘Accountable’?” after reading The American College of Physicians’ recent paper, The Patient Centered Medical Home Neighbor: The Interface of the Patient-Centered Medical Home with Specialty/Subspecialty Practices.  Stated in the paper:

The care coordination agreements should be viewed solely as a means of specifying a set of expected working procedures agreed upon by the collaborating practices toward the goals of improved communication and care coordination — they are not legally enforceable agreements between the practices.

What are the purposes of ACOs if they don’t hold physicians accountable? Kuratis emphasizes, “The big idea behind ACOs is the notion of accountability, not the specifics of care organizational structure.”

Jim Sabin M.D., a psychiatrist and director of the ethics program at Harvard, answers ‘yes’ to his question in, “Will the Accountable Care Organization (ACO) be a Durable Part of Reform?” He thinks they have the potential to solve care fragmentation. He discusses controlling health care costs and suggests ACOs are an ideal setting for physicians and patients to join together for “public deliberation” for how to ration care.

After reading the New York Times piece, “Consumers Risks Feared as Health Law Spurs Merger,” Paul Levy, president and CEO of Beth Israel Deaconess Medical Center in Boston, reflects on the market power of ACOs in “Transparency and “dial tone” to fight market power.” He rejects two suggestions proposed to combat market dominance: 1) total transparency of rates paid by each insurance company to each provider and 2) complete interoperability of medical records among providers. Instead, he agrees with a magic bullet solution that is just a click away to solving the problem of ACOs dominating the market.

by Sarah Jorgenson

Guest Blog: Patient-Experts at Medical Conventions

Andrew Schorr
Tuesday, November 30th, 2010

Andrew Schorr

Andrew Schorr is the founder and host of Patient Power ®, a website and radio program designed to connect people with news and experts on health. Want to know more about Andrew Schorr and Patient Power? Go to: www.patientpower.info or follow him on twitter.

We are invading their home turf. Increasingly, in among the thousands of doctors, scientists, and medical industry marketers at the largest medical conventions, you are finding real patients who have the conditions discussed in the scientific sessions and exhibit halls. Patients like me want to be where the news breaks; we want to ask questions and – thanks to the Internet – we have a direct line to thousands of other patients waiting to know what new developments mean for them.

I vividly remember attending an FDA drug hearing a few years ago and how there were stock analysts sitting in the audience, Blackberries poised for the thumbs up or thumbs down on whether a proposed new drug would be recommended for approval (at that session it was thumbs down). When the analysts got their thumbs moving, a biotech stock tanked in minutes, and before long, the company was announcing layoffs. Those analysts were powerful reporters.

Now patients are reporters too and their thumbs are just as powerful. So are their video cameras and microphones. These folks are a different breed than the folks from CNN, or the scientist/journalists from MedPageToday. Their questions are all-encompassing: “What do the discussions here about my disease or condition mean for me? What should change in my treatment plan? What gives me hope? What’s important for my family to know?”

That’s the nature of the interviews I conducted as a patient-reporter at last week’s American Heart Association meeting in Chicago. Unlike most people with press credentials, I wasn’t asking about this study or that data. I was asking about the broader bottom line of significance for patients. And isn’t that what’s most important?

At the meeting of the American Society of Hematology (ASH) next week I’ll be joined by other patients and the resulting interviews will be quickly posted online. My friend and fellow leukemia survivor Gretchen Cover is lined up to be a co-interviewer as we query experts in CLL. Since she helps run the 3,000 member CLL list on acor.org the questions she asks are sure to be on key issues and the answers will quickly fly out online around the world to a very specific patient population.

For me, this is thrilling! Too often the general media doesn’t have enough for patients with a specific health concern, and the medical news channels for doctors are too scientific for us. What’s significant for patients can get lost.

I am not alone in reporting as a patient for patients. My friend Mike Katz, living for years with multiple myeloma, is an ace at doing his own online video interviews and he’ll be busy at ASH too. And there are others…the numbers are growing all the time.

This is the way it should be: consumers and product developers in a close connection. There should be no “black boxes” or closed doors these days. Patients want transparency and by being on the inside of medical conventions we are getting it. Yay!

PR types and all the social networking media analysts back in New Jersey and on Madison Avenue take note: we are a new force to contend with. It is becoming less about doctor-to-doctor communication and more about patient-to-patient or expert-to-patient-to-patient. One thing to mention: the patients on the scene who matter are of the highest credibility. There are a few too many who are in the hip pocket of some of these companies, just like a few too many docs. Grassroots patient communities can see through that quicker than you can say “consulting fee.”

I hope to see you in Orlando or hope you’ll catch our reports from the big ASH meeting (I’ll have one of the badges that DOESN’T have M.D. on it). Since we’ve had two days of ice and snow here in Seattle I am really looking forward to it!

Wishing you and your family the best of health,

Andrew

Book Review: Bad Science by Ben Goldacre

Connie Davis
Monday, November 29th, 2010

Connie Davis

Connie Davis MN, ARNP is a geriatric nurse practitioner, health care consultant and William Ziff Fellow at the Center for Advancing Health. This blog was originally posted on Connie’s website where she blogs about improving the patient experience. To read other blogs by Connie and to subscribe to her RSS feed, click here.

I’ve been following evidence-based medicine for many years and I have to admit I’ve been appalled by the way it is playing out.  We have pay-for-performance that does not understand that the reliability we are after is not in reliably (read blindly) applying a guideline to a patient population, but rather reliably considering how the evidence applies to the individual in a health care interaction, we have guidelines that are based on expert opinion, often influenced by drug company funding, or based on bad science, and we have a news media that seems unable to present medical findings in a balanced and understandable way.  So we are left with a public that is confused and lacks trust in medical evidence. (Case in point: in the recent past, the diabetes guidelines championed lower BP targets for people with diabetes (and I parroted the party line), inferring a benefit from studies that have now been cast in doubt and actually seemed to have been causing harm.)

Ben Goldacre steps into this mess and endeavors to help the average person understand how to “recognize bad science when you see it.”  Through chapters that pick apart homeopathy, nutritionists and their wild claims, and the whole MMR debacle, Dr. Goldacre points out where we have gone astray.  He writes, “We get our information from the very people who have repeatedly demonstrated themselves to be incapable of reading, interpreting, and bearing reliable witness to the scientific evidence.”  He has the amazing ability to make statistics understandable and point out where the common errors in interpreting studies lie. His anecdotes and misadventures (being sued for exposing a nutritionist who is featured on British television shows, rousing conversations with homeopaths) make the point that this isn’t all innocuous.  How many children have been harmed by the bad science (actually, it was beyond bad, it was fraudulent) regarding autism and the MMR vaccination?  Ben Goldacre helps us understand how positive bias affects our conclusions, what regression to the mean is (and how it can be used to create the appearance of an effect that isn’t there) and what the placebo effect is.

This is the kind of book that would make great required reading in high school health classes.  Or medical and nursing school. The ability to critically review evidence is sorely lacking in health care professionals, and this book is much more fun to read than any of the statistics books I struggled through.

Bad Science: Quacks, Hacks, and Big Pharma Flacks, by Ben Goldacre. Faber and Faber.

Inside Health Care: A Doctor, a Nurse, and an Intern Weigh-In on EMRs on KevinMD

CFAH Staff
Wednesday, November 24th, 2010

Christopher Johnson M.D., a pediatric intensive care doctor, in his post, EMR Is Here to Stay, says “some doctors are embracing EMRs with enthusiasm; others find them unhelpful for their area of medicine.” Dr. Johnson shares concerns about differences in physician roles, responsibilities and backgrounds as well as potential conflicts from legal and commercial demands that may interfere with “taking care of the patient.” Despite these qualms, Dr. Johnson finds using an EMR is a “powerful addition to his practice” and remains optimistic about EMR’s potential. Are you optimistic?

Nurse Jared Sinclair R.N., is not optimistic in his post, How EMRs are Failing Nurses. He says that HIT companies “have yet to produce an EMR that nurses actually need.” He describes EMRs as databases where nurses “type some numbers and check some boxes, and nothing more.” He adds that nursing calls out for a “technology revolution” and challenges us to dream bigger reminding us that the “intrinsic value of technology is its ability to provide solutions to problems we never knew we had.” Do you share the same sentiments as Jared Sinclair R.N.?

Learning five EMRs in two days made an internal medicine intern, Angienadia, not only crazy but concerned about patient safety, she writes in Patient Safety Suffers When Doctors are Forced to Learn Multiple EMRs. She is shocked that a universal EMR platform is not used across all medical practices and that they don’t communicate with each other. Is it reasonable to ask new doctors to learn five unique EMRs?

What are your experiences as a patient or clinician with EMRs?

Check out their individual blogs. Dr. Christopher Johnson, pediatric intensive care doc, blogs on ChristopherJohnsonMD. Jared Sinclair R.N., an ICU nurse and pre-medical student, blogs at jaredsinclair + com. Angienadia M.D., an intern at Yale, blogs at Primary DX.

By Sarah Jorgenson